Hovedbudskap
-
En bedre forståelse av patofysiologi og risikovurdering av hver enkelt pasient vil kunne forhindre diabetiske sår og amputasjoner
-
Pasienter med diabetiske fotsår bør henvises raskest mulig til et diabetisk fotteam
-
Behandling av diabetiske fotsår er vanskelig og krevende, men tverrfaglig tilnærming kan forbedre resultatene
- 1.
Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diab Metab Res Rev 2000; 16 (suppl 1): 575 – 83.
- 2.
Henriksson F, Agardh CD, Berne C et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2000; 248: 387 – 96.
- 3.
Trautner C, Haastert B, Spraul M et al. Unchanged incidence of lower limb amputation in a German city. Diabetes Care 2001; 24: 855 – 9.
- 4.
Group TG. Epidemiology of lower limb amputations in centres in Europe, North America and East Asia. The global lower extremity amputation study group. Br J Surg 2000; 87: 328 – 37.
- 5.
Larsson J, Apelqvist J. Towards less amputations in diabetic patients: incidence, causes, cost, treatment, and prevention – a review. Acta Ortop Scand 1995; 66: 181 – 92.
- 6.
Witsø E, Rønningen H. Lower limb amputations: registration of all lower limb amputations at the University Hospital of Trondheim, Norway, 1994 – 1997. Prosthet Orthot Int 2001; 25: 181 – 5.
- 7.
Tennwall GR, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 2000; 181: 225 – 38.
- 8.
Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001; 24: 1442 – 7.
- 9.
Adler AI, Boyko EJ, Ahroni JH et al. Lower extremity amputations i diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22: 1029 – 35.
- 10.
Murray HJ, Young MJ, Hollis S et al. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996; 13: 979 – 82.
- 11.
Rith-Najaran SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high-risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992; 10: 1386 – 9.
- 12.
Thomson FJ, Veves A, Ashe H et al. A team approach to diabetic foot care – the Manchester experience. Foot 1991; 2: 75 – 82.
- 13.
Litzelmann DK, Slemende LW, Langfeld CD et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin dependant diabetes. Ann Intern Med 1993; 119: 36 – 41.
- 14.
Diabetes care and research in Europe: The St. Vincent declaration. Diabet Med 1990; 7: 360.
- 15.
The International Working Group on the Diabetic Foot. Praktiske retningslinjer – den diabetiske fot. WHO-retningslinjer for behandling av den diabetiske fot omarbeidet til norsk. 1. Oslo: Norsk interessefaggruppe for sårheling og Norges Diabetesforbund, 2001.
- 16.
Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med 2000; 17: 253 – 8.
- 17.
Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration – a role for the microcirculation? Diabet Med 1992; 9: 320 – 9.
- 18.
Cavanagh PR, Ulbrecht JS, Caputo GM. What the physician should know about diabetic foot biomechanics. I: Boulton AJ, Connor H, Cavanagh PR, red. The foot in diabetes. Chichester: J. Wiley & Sons, 2000: 33 – 59.
- 19.
Abrass CK. Fc-receptor-mediated phagocytosis: abnormalities associated with diabetes mellitus. Clin Immunol Immunopathol 1991; 1: 1 – 17.
- 20.
Greitemann B. Der diabetische Fuss. Chir Praxis 1998; 54: 279 – 96.
- 21.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977 – 86.
- 22.
Coleman WC, Birke JA. The initial foot examination in the patient with diabetes. I: Kominsky SJ, red. Medical and surgical management of the diabetic foot. St. Louis: Mosby; 1994: 7 – 27.
- 23.
Scottish Intercollegiate Guidelines Network. Section 7. Management of diabetic foot disease. www.sign.ac.uk/guidelines/fulltext/55/section7.html (19.3.2004).
- 24.
Rith-Najaran S, Branchaud C, Beaulieu O et al. Reducing lower extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract 1998; 47: 127 – 32.
- 25.
Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med 1997; 14: 867 – 70.
- 26.
Mueller MJ, Diamond JE, Sinacore DR et al. Total contact casting in treatment of diabetic plantar ulcers: controlled clinical trial. Diabet Care 1992; 12: 384 – 8.
- 27.
LeFrock JL, Joseph WS. Bone and soft-tissue infections of the lower extremities in diabetics. Clin Podiatr Med Surg 1995; 12: 87 – 103.
- 28.
Grayston ML, Gibbons GW, Balogh K et al. Probing to bone in infected pedal ulcers: A clinical sign underlying osteomyelitis in diabetic patients. JAMA 1995; 273: 721 – 3.
- 29.
Morrison WB, Ledermann HP, Schweitzer ME. MR imaging of inflammatory conditions of the ankle and foot. Magn Reson Imaging Clin N Am 2001; 9: 615 – 37.
- 30.
Lipsky BA, Berendt AR. Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev 2000; 16 (suppl): 42 – 6.
- 31.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837 – 53.
- 32.
Claudi T, Cooper JG, Midthjell K et al. NSAMs handlingsprogram for diabetes i allmennpraksis. Skriftserie for leger: Utdanning og kvalitetssikring. Oslo: Norsk selskap for allmennmedisin, Den norske lægeforening, Norges Diabetesforbund, Statens Institutt for folkehelse, 2000.
- 33.
Harding KG, Jones VJ, Price P. Topical treatment: which dressing to choose. Diabetes Metab Res Rev 2000; 16 (suppl): 547 – 50.
- 34.
Kalani M, Jorneskog G, Naderi N et al. Hyperbaric oxygen therapy (HBO) in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications 2002; 16: 153 – 8.